Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Carcinogenesis
100%
Diethylstilbestrol
100%
Phosphatidylinositol 3 Kinase
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Cytomegalovirus
66%
5 (2 Benzothiazolyl)thiomethyl 4 Hydroxy 3 Methoxybenzylidenecyanoacetamide
66%
Tamoxifen
50%
Tumor Growth
33%
Progesterone Receptor
33%
Estrogen Receptor
33%
Epileptic Absence
16%
Antiestrogen
16%
Cancer Inhibition
16%
Nude Mouse
16%
Neuroscience
In Vivo
100%
Diethylstilbestrol
100%
Phosphoinositide 3-Kinase
100%
Carcinogenesis
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Receptor Expression
66%
Cytomegalovirus
66%
Tamoxifen
50%
Progesterone Receptor
33%
Estrogen Receptor
33%
Epileptic Absence
16%
Antiestrogen
16%
Keyphrases
Estradiol
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
In Vivo Tumorigenesis
100%
Phosphoinositide 3-kinase (PI3K)
100%
AKT1
100%
Tumor
23%
Cytomegalovirus
23%
Estrogen Receptor Status
17%
Xenograft
17%
ErbB2
17%
Fold Increase
11%
Tumor Growth
11%
Tumor Volume
11%
Ovariectomized
11%
Progesterone Receptor Expression
11%
Immunohistochemical Assay
5%
MCF-7
5%
Dominant Negative
5%
In Vivo Growth
5%
Tumor Inhibition
5%
Estradiol Priming
5%
Athymic nude Mice
5%
Estrogen Supplementation
5%
Estradiol Treatment
5%
ErbB Inhibitor
5%
Akt1 Phosphorylation
5%
Akt Phosphorylation
5%
Antiestrogen
5%
Animal Tumors
5%
MCF-7 Cells
5%
Constitutively Active
5%
MCF-7 Xenograft
5%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Estradiol
100%
Carcinogenesis
100%
Phosphoinositide 3-Kinase
100%
Cytomegalovirus
66%
Tumor Progression
50%
Progesterone Receptor
33%
Tumor Volume
33%
Ovariectomized Animal
33%
Estrogen Receptor
33%
Nude Mouse
16%
Growth Inhibition
16%
Immunology and Microbiology
Xenograft
100%
Cytomegalovirus
100%
Gamma Urogastrone
100%
Tumor Volume
50%
Growth Inhibition
25%
Nude Mouse
25%
Epidermal Growth Factor
25%